Pergolide has been the mainstay treatment of Equine Cushing’s disease, also known as pituitary pars intermedia dysfunction, for several de
"Effective Dec. 1, horses that are granted a therapeutic use exemption for pergolide can remain on pergolide with no withdrawal of drug prior to competition and no need to file a medication report form each time they compete."













